Many Healthcare workers must deal on a daily basis with the transportation, preparation, storage, clean up, and disposal of cytotoxic drugs, which are used in chemotherapy because of their harmful effect on cancer cells. These drugs also have harmful effects on good cells, and they therefore pose a significant health risk to those who work with them. Yet there is little safety and health information available about them, and what information is available is scattered across a vast array of literature. The Safety and Health Handbook for Cytotoxic Drugs collects this information so that healthcare workers can better understand the drugs they work with and the safety and health procedures that should be followed. In it, author Samuel J. Murff presents comprehensive technical and procedural information on 106 of the most common cytotoxic drugs. The book provides guidance on quickly dealing with spills, reducing unnecessary exposure, and complying with pertinent regulations and standards in order to better equip healthcare workers to maintain a safe work environment.
Presentations need not be an ordeal. For medics and scientists they are an integral part of their professional working life determining how their work is perceived by peers students superiors potential employers and grant-awarding bodies. This book answers the commonest questions about scientific presentations and helps avoid the typical problems and pitfalls that may be encountered when making a presentation. Its numerous practical tips can be found whenever needed and applied immediately. Presenting in Biomedicine is an invaluable aid helping readers to prepare and carry out effective presentations confidently. Doctors medical students biomedical researchers and academics will find this book essential reading.
This is the second edition of the WHO handbook on the safe, sustainable and affordable management of health-care waste--commonly known as "the Blue Book". The original Blue Book was a comprehensive publication used widely in health-care centers and government agencies to assist in the adoption of national guidance. It also provided support to committed medical directors and managers to make improvements and presented practical information on waste-management techniques for medical staff and waste workers. It has been more than ten years since the first edition of the Blue Book. During the intervening period, the requirements on generators of health-care wastes have evolved and new methods have become available. Consequently, WHO recognized that it was an appropriate time to update the original text. The purpose of the second edition is to expand and update the practical information in the original Blue Book. The new Blue Book is designed to continue to be a source of impartial health-care information and guidance on safe waste-management practices. The editors' intention has been to keep the best of the original publication and supplement it with the latest relevant information. The audience for the Blue Book has expanded. Initially, the publication was intended for those directly involved in the creation and handling of health-care wastes: medical staff, health-care facility directors, ancillary health workers, infection-control officers and waste workers. This is no longer the situation. A wider range of people and organizations now have an active interest in the safe management of health-care wastes: regulators, policy-makers, development organizations, voluntary groups, environmental bodies, environmental health practitioners, advisers, researchers and students. They should also find the new Blue Book of benefit to their activities. Chapters 2 and 3 explain the various types of waste produced from health-care facilities, their typical characteristics and the hazards these wastes pose to patients, staff and the general environment. Chapters 4 and 5 introduce the guiding regulatory principles for developing local or national approaches to tackling health-care waste management and transposing these into practical plans for regions and individual health-care facilities. Specific methods and technologies are described for waste minimization, segregation and treatment of health-care wastes in Chapters 6, 7 and 8. These chapters introduce the basic features of each technology and the operational and environmental characteristics required to be achieved, followed by information on the potential advantages and disadvantages of each system. To reflect concerns about the difficulties of handling health-care wastewaters, Chapter 9 is an expanded chapter with new guidance on the various sources of wastewater and wastewater treatment options for places not connected to central sewerage systems. Further chapters address issues on economics (Chapter 10), occupational safety (Chapter 11), hygiene and infection control (Chapter 12), and staff training and public awareness (Chapter 13). A wider range of information has been incorporated into this edition of the Blue Book, with the addition of two new chapters on health-care waste management in emergencies (Chapter 14) and an overview of the emerging issues of pandemics, drug-resistant pathogens, climate change and technology advances in medical techniques that will have to be accommodated by health-care waste systems in the future (Chapter 15).
Outlines the commitment of various government agencies to biotechnology industries in Australia. Includes statements from AusIndustry, Biotechnology Australia, Invest Australia.
Written expressly for nurses caring for patients with cancer, the 2010 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. An essential reference updated annually, the text provides valuable information on effective symptom management, patient education, and chemotherapy administration. Completely revised and updated, the 2010 Oncology Nursing Drug Handbook includes: New and updated administered drugs. Specific drugs are described in terms of their mechanism of action, metabolism, drug interactions, laboratory effects/interference, and special considerations. The most important and common drug side effects are discussed.
Written Expressly For Nurses Caring For Patients With Cancer, The 2009 Oncology Nursing Drug Handbook Uniquely Expresses Drug Therapy In Terms Of The Nursing Process: Nursing Diagnoses, Etiologies Of Toxicities, And Key Points For Nursing Assessment, Intervention, And Evaluation. An Essential Reference Updated Annually, The Text Provides Valuable Information On Effective Symptom Management, Patient Education, And Chemotherapy Administration. Completely Revised And Updated, The 2009 Oncology Nursing Drug Handbook Includes: - New, Administered Drugs: Amrubicin, Patupilone; Levoleucovorin, Dexrazoxane For Injection (Extravasation), Casopitant, Fosaprepitant, Granisetron Hcl Transdermal, Desvenlafaxine, Denosumab, Methlnaltrexone Bromide - Drug Updates For Bendamustine And Ixapapilone - Specific Drugs Are Described In Terms Of Their Mechanism Of Action, Metabolism, Drug Interactions, Laboratory Effects/Interference, And Special Considerations. The Most Important And Common Drug Side Effects Are Also Discussed.
Written especially for nurses caring for patients with cancer, the 2013 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.
A new and updated version of this best-selling resource! Jones and Bartlett Publisher's 2011 Nurse's Drug Handbook is the most up-to-date, practical, and easy-to-use nursing drug reference! It provides: Accurate, timely facts on hundreds of drugs from abacavir sulfate to Zyvox; Concise, consistently formatted drug entries organized alphabetically; No-nonsense writing style that speaks your language in terms you use everyday; Index of all generic, trade, and alternate drug names for quick reference. It has all the vital information you need at your fingertips: Chemical and therapeutic classes, FDA pregnancy risk category and controlled substance schedule; Indications and dosages, as well as route, onset, peak, and duration information; Incompatibilities, contraindications; interactions with drugs, food, and activities, and adverse reactions; Nursing considerations, including key patient-teaching points; Vital features include mechanism-of-action illustrations showing how drugs at the cellular, tissue, or organ levels and dosage adjustments help individualize care for elderly patients, patients with renal impairment, and others with special needs; Warnings and precautions that keep you informed and alert.
Written especially for nurses caring for patients with cancer, the 2015 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.
Written especially for nurses caring for patients with cancer, the 2016 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation.
